**Exhibit 31.1**Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002CERTIFICATIONI, Rik J. Deitsch, Chief Executive Officer and Chief Financial Officer ofNutra Pharma Corp., certify that:1. I have reviewed this quarterly report on Form 10-QSB for the fiscal quarter endedSeptember 30, 2005, of Nutra Pharma Corp.;2. Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, not misleading withrespect to the period covered by this report;3. Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periods presentedin this report;4. As the registrant’s certifying officer(s), I am responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) and internal control over financial reporting (as defined in Exchange ActRules 13a-15(f) and 15d-15(f)) for the registrant and have:     a. Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under my supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, is madeknown to us by others within those entities, particularly during the period in which thisreport is being prepared;     b. Designed such internal control over financial reporting, or caused such internalcontrol over financial reporting to be designed under my supervision, to providereasonable assurance regarding the reliability of financial reporting and the preparation offinancial statements for external purposes in accordance with generally acceptedaccounting principles;     c. Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report my conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluation; and     d. Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recentfiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and5. As the registrant’s certifying officer(s), I have disclosed, based on our most recentevaluation of internal control over financial reporting, to theregistrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions):     a. All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information; and     b. Anyfraud, whether or not material, that involves management or other employees who have a significant rolein the registrant’s internal control over financial reporting.Date: November 21, 2005        /s/ Rik J. Deitsch    Rik J. Deitsch    Chief Executive Officer and Chief Financial Officer